Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 6
2004 6
2005 2
2006 9
2007 4
2008 3
2009 4
2010 8
2011 3
2012 3
2013 2
2014 4
2015 6
2016 6
2017 3
2018 6
2019 11
2020 6
2021 3
Text availability
Article attribute
Article type
Publication date

Search Results

87 results
Results by year
Filters applied: . Clear all
Page 1
Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial.
Paz-Ares L, Kim TM, Vicente D, Felip E, Lee DH, Lee KH, Lin CC, Flor MJ, Di Nicola M, Alvarez RM, Dussault I, Helwig C, Ojalvo LS, Gulley JL, Cho BC. Paz-Ares L, et al. Among authors: di nicola m. J Thorac Oncol. 2020 Jul;15(7):1210-1222. doi: 10.1016/j.jtho.2020.03.003. Epub 2020 Mar 13. J Thorac Oncol. 2020. PMID: 32173464 Clinical Trial.
Immunotherapy-based combinations: an update.
Fucà G, de Braud F, Di Nicola M. Fucà G, et al. Among authors: di nicola m. Curr Opin Oncol. 2018 Sep;30(5):345-351. doi: 10.1097/CCO.0000000000000466. Curr Opin Oncol. 2018. PMID: 29994900 Review.
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer.
Castagnoli L, Cancila V, Cordoba-Romero SL, Faraci S, Talarico G, Belmonte B, Iorio MV, Milani M, Volpari T, Chiodoni C, Hidalgo-Miranda A, Tagliabue E, Tripodo C, Sangaletti S, Di Nicola M, Pupa SM. Castagnoli L, et al. Among authors: di nicola m. Oncogene. 2019 May;38(21):4047-4060. doi: 10.1038/s41388-019-0700-2. Epub 2019 Jan 31. Oncogene. 2019. PMID: 30705400 Free PMC article.
SPARC Is a New Myeloid-Derived Suppressor Cell Marker Licensing Suppressive Activities.
Sangaletti S, Talarico G, Chiodoni C, Cappetti B, Botti L, Portararo P, Gulino A, Consonni FM, Sica A, Randon G, Di Nicola M, Tripodo C, Colombo MP. Sangaletti S, et al. Among authors: di nicola m. Front Immunol. 2019 Jun 20;10:1369. doi: 10.3389/fimmu.2019.01369. eCollection 2019. Front Immunol. 2019. PMID: 31281314 Free PMC article.
Safety, Tolerability, and Potential Clinical Activity of a Glucocorticoid-Induced TNF Receptor-Related Protein Agonist Alone or in Combination With Nivolumab for Patients With Advanced Solid Tumors: A Phase 1/2a Dose-Escalation and Cohort-Expansion Clinical Trial.
Heinhuis KM, Carlino M, Joerger M, Di Nicola M, Meniawy T, Rottey S, Moreno V, Gazzah A, Delord JP, Paz-Ares L, Britschgi C, Schilder RJ, O'Byrne K, Curigliano G, Romano E, Patah P, Wang R, Liu Y, Bajaj G, Siu LL. Heinhuis KM, et al. Among authors: di nicola m. JAMA Oncol. 2019 Nov 7;6(1):1-8. doi: 10.1001/jamaoncol.2019.3848. Online ahead of print. JAMA Oncol. 2019. PMID: 31697308 Free PMC article.
High Doses of Antimetabolites Followed by High-Dose Sequential Chemoimmunotherapy and Autologous Stem-Cell Transplantation in Patients With Systemic B-Cell Lymphoma and Secondary CNS Involvement: Final Results of a Multicenter Phase II Trial.
Ferreri AJ, Donadoni G, Cabras MG, Patti C, Mian M, Zambello R, Tarella C, Di Nicola M, D'Arco AM, Doa G, Bruno-Ventre M, Assanelli A, Foppoli M, Citterio G, Fanni A, Mulè A, Caligaris-Cappio F, Ciceri F. Ferreri AJ, et al. Among authors: di nicola m. J Clin Oncol. 2015 Nov 20;33(33):3903-10. doi: 10.1200/JCO.2015.61.1236. Epub 2015 Aug 17. J Clin Oncol. 2015. PMID: 26282634 Clinical Trial.
Immunotherapy advances in uro-genital malignancies.
Ratta R, Zappasodi R, Raggi D, Grassi P, Verzoni E, Necchi A, Di Nicola M, Salvioni R, de Braud F, Procopio G. Ratta R, et al. Among authors: di nicola m. Crit Rev Oncol Hematol. 2016 Sep;105:52-64. doi: 10.1016/j.critrevonc.2016.06.012. Epub 2016 Jun 17. Crit Rev Oncol Hematol. 2016. PMID: 27372200 Review.
Lymphoma Immunotherapy: Current Status.
Zappasodi R, de Braud F, Di Nicola M. Zappasodi R, et al. Among authors: di nicola m. Front Immunol. 2015 Sep 1;6:448. doi: 10.3389/fimmu.2015.00448. eCollection 2015. Front Immunol. 2015. PMID: 26388871 Free PMC article. Review.
87 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page